中国医药行业市场研究分析(英文105页)

    2013-11-17

    中国医药行业市场研究分析(英文105页)

    betway必威体 &论文资料网
    betway必威体 &论文资料网

    Table of Contents

    IMS MARKET PROGNOSIS .........6

    MARKET OVERVIEW AND FORECASTS .........7

    MARKET SYNOPSIS ............ 7
    TOTAL MARKET FORECASTS 2012-2016 ........... 9
    ANALYSIS OF REBATES AND DISCOUNTS .............. 9
    SUMMARY OF THE PROGNOSIS .......... 9
    HOSPITAL SECTOR OVERVIEW ............. 11
    HOSPITAL SECTOR FORECASTS ........ 13
    EVENT ANALYSIS ............. 15
    FORECASTING DATA AND METHODS ............. 20
    DATA SOURCES ........... 20
    BASELINE EXTRAPOLATIONS ........... 20
    HOSPITAL SECTOR BASELINE EXTRAPOLATIONS ........... 21
    ECONOMIC INDICATORS ........ 22
    THERAPEUTIC CLASS FORECASTS ........ 23
    IMS MARKET PROGNOSIS REPORT ...........25
    BUSINESS ENVIRONMENT ...............26
    ECONOMIC ENVIRONMENT ......... 26
    ECONOMIC GROWTH ............. 26
    INFLATION ......... 26
    POPULATION, EMPLOYMENT AND INCOME ........... 26
    FISCAL POLICY ............. 27
    MONETARY POLICY ................ 27
    FOREIGN TRADE AND CURRENT ACCOUNT ........... 27
    EXCHANGE RATE .......... 28
    POLITICAL ENVIRONMENT .......... 30
    POLITICAL INSTITUTIONS ............... 30
    CURRENT GOVERNMENT ......... 30
    18th PARTY CONGRESS 2012 ........... 31
    WUKAN VILLAGE PROTEST .............. 32

    INTERNATIONAL RELATIONS ............ 32

    HEALTHCARE ENVIRONMENT ...........33

    HEALTHCARE PROVISION ........... 33
    Market Prognosis Scenario 2012-2016: Healthcare Provision ............. 33
    HEALTHCARE SYSTEM ............ 34
    HEALTH STATUS ........... 36
    HEALTHCARE FINANCING AND EXPENDITURE ............... 38
    PHARMACEUTICAL EXPENDITURE .............. 38
    HEALTHCARE POLICY ............. 41
    DRUG POLICY .............. 42
    HEALTH INSURANCE .............. 43
    HOSPITAL SECTOR ................ 45
    HOSPITAL DRUG PROCUREMENT ............... 48
    COMMUNITY CARE ........ 50
    PRESCRIBING AND DISPENSING .......... 52
    Market Prognosis Scenario 2012-2016: Prescribing and Dispensing ............. 52
    PRESCRIBING INFLUENCES .............. 52
    ANTIBIOTIC PRESCRIBING .............. 55
    ESSENTIAL DRUG LIST ........... 56
    NATIONAL REIMBURSEMENT DRUG LIST ............. 56
    PATIENT CO-PAYMENT ........... 58
    HOSPITAL FORMULARIES ................ 58
    PRESCRIPTION-ONLY POLICY ........... 58
    SEPARATION OF PRESCRIBING AND DISPENSING .......... 58
    PRICING ................ 59
    Market Prognosis Scenario 2012-2016: Pricing .............. 59
    PRICING SYSTEM ......... 59
    PRICING POLICY REFORM ................ 60
    PRICE MONITORING .............. 62
    PRICE CUTS ........ 62
    PRICE TRENDS ............. 63
    PHARMACOECONOMICS ......... 64
    DISCOUNTS AND MARGINS ............. 64
    REGULATORY ENVIRONMENT ............... 66
    Market Prognosis Scenario 2012-2016: Regulatory Environment ........ 66
    STATE FOOD AND DRUG ADMINISTRATION ......... 67
    PRODUCT REGISTRATION ................ 67
    CLINICAL TRIALS ......... 68
    GOOD MANUFACTURING PRACTICE ............ 68
    POST-MARKETING SURVEILLANCE ............. 69
    MARKETING AND PROMOTION ......... 69
    COUNTERFEITS ............ 70
    INTELLECTUAL PROPERTY ................ 70
    PHARMACEUTICAL BUSINESS ENVIRONMENT .......... 72
    Market Prognosis Scenario 2012-2016: Pharmaceutical Business Environment ................ 72
    OPERATING ENVIRONMENT ............. 73
    INDUSTRY STRUCTURE .......... 74
    LEADING CORPORATIONS ............... 76
    LEADING PRODUCTS .............. 77
    FOREIGN INVESTMENT ........... 77
    RESEARCH AND DEVELOPMENT ........ 78
    GENERICS MARKET ................ 79
    DISTRIBUTION ............. 80
    RETAIL PHARMACY ................ 81
    OTC MARKET ............... 82
    SALES AND MARKETING ......... 83

    APPENDIX A: GLOSSARY ........85

    APPENDIX B: SOURCES AND METHODS .............87

    COVERAGE ............. 87
    MARKET FORECASTS ............. 88
    MARKET SEGMENTATION FORECASTS ........ 88
    THERAPEUTIC CLASS FORECASTS ............. 88
    REGIONAL OVERVIEWS .......... 89
    FORECASTING METHODOLOGY ............ 90
    TOTAL MARKET FORECASTING PROCESS ............. 90
    MARKET SEGMENTATION FORECASTING PROCESS ........ 91
    THERAPEUTIC CLASS FORECASTING PROCESS .............. 93
    SOURCES ............... 94
    PRIMARY AND SECONDARY MARKET RESEARCH ............ 94
    PHARMACEUTICAL MARKET DATA .............. 94
    PHARMACEUTICAL MARKET COVERAGE .......... 95
    EVENT IMPACT CALCULATION .............. 96
    DEMOGRAPHIC CHANGES ................ 96
    NEW PRODUCT LAUNCHES ............... 99
    CALCULATION OF GENERIC COMPETITION ........... 99
    USEFUL DEFINITIONS .............. 101
    COMPOUND ANNUAL GROWTH RATE ........ 101
    CONSTANT PRICE ................ 101
    LASPEYRES INDEX ............... 101
    STANDARD UNITS ............... 102
    GENERIC DEFINITION USING THE IMS MIDAS MARKET SEGMENTATION FEATURE ........ 102
    GENERIC DEFINITION WITHOUT THE MARKET SEGMENTATION FEATURE ............ 103
    betway必威体 &论文资料网
    [报告关键词]： 医药
    betway必威体 &论文资料网

    专题跟踪研究报告

    企业出海 新质生产力 低空经济 生成式AI 工业互联网 数字藏品 动力电池 ESG 数字化转型 机械零部件 氢能 碳中和 区块链 元宇宙 建筑 矿产 安永 数字货币 新基建 日化 案例分析 毕马威 贝恩咨询 普华永道 波士顿 罗兰贝格 德勤咨询 埃森哲 麦肯锡 电商 金融科技 人工智能 物联网 互联网金融 大数据 3D打印 食品饮料 家电行业 零售连锁 新能源 商业地产 快递行业 机械设备 汽车 核电 电子产业 电力行业 新兴产业 纺织服装 医药生物 广告传媒 金融投资 航空 旅游 酒业 能源 有色金属 通信 石油化工 物流供应链 房地产 可行性报告 PPP 商业计划书 五力分析 并购重组 发展战略 SWOT 产业链 钻石模型 价值链 PEST 人力资源 面板模型 stata 精华推荐 供应链金融 互联网+ 机器人 O2O 教育培训 论文资料查找 写作修改服务 EMBA论文写作 硕士论文 本科论文 论文写作
    进入
    合作共赢，共创未来

    需要行业报告相关资料和报告？

    点此填写您的需求

    15+年的经验，值得信赖

    **涉及个人信息严格保密，敬请放心

    商务服务

    可以微信或者电话联系：18121118831

    商业计划书

    商务文档撰写

    点击查看详细

    可行性研究报告

    商务咨询业务

    点击查看详细

    物流产业园区规划

    商务咨询业务

    点击查看详细

    PPT设计制作

    商务PPT制作

    点击查看详细

    Baidu
    map